Pulmonology

NUCALA

NUCALA (mepolizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells.
Infusion or injection therapy referral
What it treats Severe Eosinophilic Asthma & Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Prescribed by Pulmonologists & Immunologists
How it’s administered Subcutaneous injection
Frequency Once a month
Length of treatment 10 minutes or less

About This Therapy

NUCALA (mepolizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells. Specifically, it is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) for patients with severe eosinophilic asthma and patients with eosinophilic granulomatosis polyangiitis (EGPA).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

NUCALA REFERRAL FORM

NUCALA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for NUCALA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.